COVID-19 Therapeutics Accelerator For letting the science lead the funding on potential COVID-19 treatments
Backed by major players ranging from Mastercard to The Bill & Melinda Gates Foundation to Wellcome, the US$125 million COVID-19 Therapeutics Accelerator aims to identify, accelerate and scale potential COVID-19 treatments by coordinating R&D efforts.